Scientists hunt for clues to stop uterus transplants from failing

NCT ID NCT04615221

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study aims to understand why the immune system sometimes rejects a transplanted uterus. Researchers will analyze blood, tissue, and swab samples from 30 women who have received or will receive a uterine transplant, as well as from donors and healthy volunteers. The goal is to find non-invasive markers that could predict rejection early, without needing a biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better ways to detect and prevent rejection in uterine transplants, improving success rates.

What could go wrong

This is an early observational study with only 30 participants, so findings may not apply to everyone. It does not test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRANSPLANT REJECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

transplant rejection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hopital Foch

    RECRUITING

    Suresnes, 92151, France

    Contact Email: •••••@•••••